- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/38 - Antigènes de serpents
Détention brevets de la classe A61K 39/38
Brevets de cette classe: 464
Historique des publications depuis 10 ans
33
|
25
|
20
|
16
|
12
|
10
|
1
|
1
|
2
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Selecta Biosciences, Inc. | 191 |
18 |
The Trustees of the University of Pennsylvania | 4273 |
9 |
The Board of Trustees of the University of Illinois | 2668 |
8 |
IDEXX Laboratories, Inc. | 781 |
7 |
Intervet Inc. | 872 |
7 |
Zoetis Services LLC | 1556 |
7 |
Glaxosmithkline Biologicals S.A. | 1699 |
6 |
The Board of Trustees of the Leland Stanford Junior University | 6259 |
6 |
Cornell University | 3215 |
6 |
The Regents of the University of California | 19572 |
5 |
The Johns Hopkins University | 5540 |
5 |
The General Hospital Corporation | 4655 |
5 |
Idera Pharmaceuticals, Inc. | 96 |
5 |
The United States of America as represented by the Secretary of the Department of Health and Human Services | 185 |
5 |
Novartis Vaccines and Diagnostics, Inc. (a Delaware corporation) | 63 |
4 |
Boehringer Ingelheim Vetmedica, Inc. | 119 |
4 |
Wyeth LLC | 669 |
4 |
Crucell Holland B.V. | 101 |
4 |
ID Biomedical Corporation of Quebec | 30 |
4 |
The United States of America as represented by the Department of Veterans Affairs | 305 |
4 |
Autres propriétaires | 341 |